This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Sign In   |   Register
News: Publications

Journal highlights June: Management of CVD risk by lowering of plasma cholesterol

Friday 12 July 2019   (0 Comments)
Share |

In our regular feature, Editor-in-Chief Arnold von Eckardstein highlights interesting articles from recent issues of Atherosclerosis journal. The highlights are an easy way for you to get an overview of the issue content every month.

It is now widely accepted that lowering of plasma cholesterol is a mainstay in the management of cardiovascular risk. However, the lower-the-better concept is not perfectly translated into clinical practice. Reasons and consequences of this gap are addressed by several articles in this issue of Atherosclerosis: incomplete adherence, very high risk or cholesterol levels at baseline, difficult differential diagnosis of rare dyslipidemia, finding the right time-point to initiate treatment, monitoring treatment success in the vasculature, or unknown reasons of hypercholesterolemia.

To Journal Highlights June >>

To the June issue of Atherosclerosis >>

 

Atherosclerosis is now present on Facebook (Atherosclerosis - Journal of the European Atherosclerosis Society) and Twitter (@ATHjournal). Join our social media community and follow us!


Membership Software Powered by YourMembership  ::  Legal